Loading clinical trials...
Loading clinical trials...
A double-blind and placebo-controlled study is conducted in the current human study. The purpose of this study is to investigate the effects of n-3 PUFA intervention on glucose and lipid homeostasis ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhejiang University
NCT06062394 · Hypertension, Hyperlipidemias
NCT06984822 · Diabetic Macular Edema, Visual Impairment, and more
NCT06903897 · Hyperlipidemias, Diabetes, and more
NCT06055036 · Cardiometabolic Syndrome, Physical Inactivity, and more
NCT05802121 · Prostate Cancer, Metabolic Syndrome, and more
Lanxi Red Cross Hospital
Jinhua, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions